The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
#5403Business Leadership Series43.0 / 100Get badge
← The Index
Business Leadership Series artwork
LeadershipNEW this period

Business Leadership Series

Hosted by Business Leadership Series

Our audience is comprised of business owners, leaders, and entrepreneurs who desire to learn from our guests’ knowledge, advice, and experience for personal and professional growth. We interview pro athletes, rock and roll hall of famers, best selling authors, and other leaders with an inspiring story.

100 episodes · publishes weekly · latest 2026-06-28 · ~33 min/episode

Rank

#5403

Substance

43.0

/ 100

Breakdown

Scored 2026-07
Updated monthly

Leadership rank

#829 of 1041

Best B2B Leadership Podcasts →

Across the index

#5403 of 6182

Substance

Top 87%

outscores 13% of the index

Why it scores where it does

Business Leadership Series ranks #5403 on The B2B Podcast Index with a substance score of 43.0 out of 100, scored across 1 recent episode. It scores highest on guest caliber and specificity & evidence. Dr. Fagenbaum is a genuine practitioner who founded a real research network, ran lab experiments on his own samples, and identified a drug candidate himself - credible work done at real stakes. However, from a B2B operator standpoint he is essentially irrelevant; his domain expertise is rare-disease research, not business operations.

The five-dimension breakdown

Averaged across 1 recently scored episode, with cited evidence.

Insight Density

7.0 / 20

This episode is almost entirely a personal memoir recitation with no actionable B2B insights. The handful of lessons extracted ('think it, do it,' the overtime metaphor) are thin motivational platitudes, not novel ideas a smart operator hadn't already heard.

“I call it, think it, do it. And it's basically, you know, if you think about doing it, if it's the right thing to do, you should do it.”

“you miss, you miss 100% of the shots that you don't take”

Originality

8.0 / 20

The guest's personal story is genuinely singular, but every lesson extracted reduces to well-worn motivational tropes. The Wayne Gretzky quote, the regret-of-omission framework, and the 'every second counts' urgency messaging are among the most recycled concepts in inspirational content.

“you miss, you miss 100% of the shots that you don't take”

“I didn't regret anything that I did do in my life. And I didn't regret anything that I did say. What I regretted were the things that I did not do”

Guest Caliber

12.0 / 20

Dr. Fagenbaum is a genuine practitioner who founded a real research network, ran lab experiments on his own samples, and identified a drug candidate himself - credible work done at real stakes. However, from a B2B operator standpoint he is essentially irrelevant; his domain expertise is rare-disease research, not business operations.

“I began conducting laboratory research myself. So I got space in a nearby laboratory where I could start performing experiments on my own samples”

“starting a foundation called the Castleman Disease Collaborative Network to take a unique approach to advancing research”

Specificity & Evidence

9.0 / 20

There are a handful of concrete figures (5,000 US diagnoses per year, five relapses, a specific wedding date, 5.5 years in remission) but every specific number is personal or medical. There is zero business data - no revenue, no hiring decisions, no operational metrics - making the specificity largely irrelevant to a B2B audience.

“There are about 5,000 patients diagnosed each year in the U.S. with Castleman disease”

“about a third of us die within five years of diagnosis. Another third will die within 10 years of diagnosis”

Conversational Craft

7.0 / 20

The host repeatedly inserts his own personal anecdotes, delivers extended affirmations ('I've got goosebumps,' 'absolutely profound'), and never asks a probing or challenging follow-up. Questions are uniformly 'what was that like?' in form, and the interview functions as an uninterrupted PR vehicle for the guest's book.

“I've had health scares where I thought I thought I had a heart attack and was fighting for my life and it changed my life. And then I was okay. And it was nothing compared to the fight that you're going through”

“Wow. Again, thank you for sharing that making the most of every day.”

Standout episodes

  • Episode 1474: Race For The Cure

    2026-06-28

    43

Rank over time

First period on the Index - history builds from here.

Episodes

1 scored on substance · 60 tracked in total.

  • Episode 1474: Race For The Cure

    2026-06-28 · 25 min

    43 / 100

Frequently asked

What is Business Leadership Series's substance score?
Business Leadership Series scores 43.0 out of 100 for substance and ranks #5403 on The B2B Podcast Index. That puts it ahead of 13% of the B2B podcasts we rank and #829 of 1041 in Leadership. The score reflects insight density, originality, guest caliber, specificity and conversational craft across recent episodes - not downloads.
Is Business Leadership Series worth listening to?
Business Leadership Series is ranked on The B2B Podcast Index with a substance score of 43.0/100. See the five-dimension breakdown above to judge whether it fits what you're after.
Who hosts Business Leadership Series?
Business Leadership Series is hosted by Business Leadership Series.
How often does Business Leadership Series publish?
Business Leadership Series publishes weekly, has 100 episodes, released its most recent episode on 2026-06-28.
Which Business Leadership Series episode should I start with?
Our highest-scoring recent episode is "Episode 1474: Race For The Cure" (43/100) - a good place to start.

Show off your #829 rank in Leadership

Add this badge to your site - it links back here and updates automatically as you rank.

Ranked #829 on The B2B Podcast Index
Embed code
<a href="https://index.fame.so/show/business-leadership-series" target="_blank" rel="noopener">
  <img src="https://index.fame.so/badge/business-leadership-series/badge.svg" alt="Ranked #829 on The B2B Podcast Index" width="360" height="136" />
</a>
Markdown & other formats →

Track Business Leadership Series's rank

Get an email whenever this show moves up or down the Index. Monthly at most, no spam.

Listen / subscribe:WebsiteRSS

Guests who've appeared

Dr. David Fagenbaum

Topics this show covers

The themes that come up most across this show's episodes.

GlioblastomaIdiopathic multicentric Castleman diseaseCastleman Disease Collaborative NetworkOff-label drug repurposingRare disease researchChasing My Cure (memoir)Georgetown University footballUniversity of Pennsylvania medical schoolMulti-agent chemotherapyPatient-physician-researcher collaboration

More Leadership podcasts

See all →
  • Invest Like the Best with Patrick O'Shaughnessy

    Colossus | Investing & Business Podcasts

    89.0
  • WorkLab

    Microsoft

    86.4
  • The Beautiful Business Podcast

    The Wow Company

    85.0
  • The Business Owner's Journey

    Nick Berry

    85.0
  • Radio Advisory

    Advisory Board

    83.2
  • Connect 2 Develop

    Marney Reid and Erika DeLeon

    82.0

Similar shows

Podcasts that dig into the same topics.

  • The Education of a Value Investor

    Guy Spier

    60.0
  • The Patients’ Voice: Exposing the Truth in Healthcare

    Krista Hughes - BCPA, Founder and CEO of Hughes Advocacy

    48.3